Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Induction of general anaesthesia
Age: Adult
Dose: Inhalation – 0.5% v/v of halothane in oxygen or mixture of nitrous oxide and oxygen, increase gradually according to response to a concentration of 2-4% v/v
Note: Increase gradually according to response
Indication: Maintenance of general anaesthesia
Age: Adult
Dose: Inhalation – 0.5-2% v/v
Note: Depending on the flow rate used

Child Dose

Clinical InformationAdministration Information
Indication: Induction of general anaesthesia
Age: Child
Dose: Inhalation – 1.5-2% volume by volume
Indication: Maintenance of general anaesthesia
Age: Child
Dose: Inhalation – 0.5-1.5% volume by volume
Administration
  • Hospital use only
  • Given by anesthetist
Side Effect

Drug Interaction

Drug NameRisk Factors
Epinephrine
Increased risk of ventricular dysrhythmias
Suxamethonium
Increased risk of malignant hyperthermia

Disease Interaction

Disease NameRisk Factors
Malignant Hyperthermia
Can trigger life-threatening reactions
Raised CSF Pressure
Can increase brain pressure

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Bottles of Halothane must be securely closed and stored in a cool dry place, protected from light. Halothane must be kept in the original container until immediately prior to its use.

Whilst in the liquid phase, Halothane must not be diluted or contaminated; however, in the vapour phase it may be administered together with Oxygen or a mixture of Nitrous Oxide and Oxygen.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.